<SEC-DOCUMENT>0001213900-24-029928.txt : 20240403
<SEC-HEADER>0001213900-24-029928.hdr.sgml : 20240403
<ACCEPTANCE-DATETIME>20240403171959
ACCESSION NUMBER:		0001213900-24-029928
CONFORMED SUBMISSION TYPE:	8-K12B
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20240403
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240403
DATE AS OF CHANGE:		20240403

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NewGenIvf Group Ltd
		CENTRAL INDEX KEY:			0001981662
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			D8

	FILING VALUES:
		FORM TYPE:		8-K12B
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42004
		FILM NUMBER:		24820107

	BUSINESS ADDRESS:	
		STREET 1:		13/F, PS TOWER, SUKHUMVIT 21 RD (ASOKE)
		CITY:			BANGKOK
		STATE:			W1
		ZIP:			0000
		BUSINESS PHONE:		852-2861-1666

	MAIL ADDRESS:	
		STREET 1:		1/F, PIER 2, CENTRAL
		CITY:			HONG KONG
		STATE:			K3
		ZIP:			999077

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ASPAC I Mini Acquisition Corp.
		DATE OF NAME CHANGE:	20230614
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K12B
<SEQUENCE>1
<FILENAME>ea0203267-8k12b_newgenivf.htm
<DESCRIPTION>8-K12B
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt; width: 100%"><DIV STYLE="margin-right: 0pt; font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; margin-left: 0pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNITED
STATES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Washington,
D.C. 20549</FONT></P>

<P STYLE="margin: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORM
6-K</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REPORT
OF FOREIGN PRIVATE ISSUER <BR>
PURSUANT TO RULE 13a-16 OR 15d-16</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNDER
THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="margin: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the month of April 2024</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Commission
File Number:</B></FONT></P>

<P STYLE="margin: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NewGenIvf
Group Limited</B></FONT></P>

<P STYLE="margin: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>36/39-36/40, 13th Floor, PS Tower </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Sukhumvit 21 Road (Asoke) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Khlong Toei Nuea Sub-district </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Watthana District, Bangkok 10110 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Thailand</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<B>Address
of principal executive office</B>)</FONT></P>

<P STYLE="margin: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</FONT></P>

<P STYLE="margin: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
20-F &#9746;&nbsp;&nbsp;&nbsp;&nbsp;Form 40-F &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPLANATORY
NOTE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 3, 2024, A SPAC I Acquisition Corp. (&ldquo;ASCA&rdquo;), A SPAC I Mini Acquisition Corp. (the then name of NewGenIvf Group Limited),
a British Virgin Islands business company (&ldquo;NewGenIvf&rdquo;), A SPAC I Mini Sub Acquisition Corp., a Cayman Islands exempted company
and wholly-owned subsidiary of NewGenIvf, and NewGenIvf Limited, a Cayman Islands exempted company completed a business combination transaction
pursuant to that certain Merger Agreement, dated as of February 15, 2023 (as amended on June 12, 2023, December 6, 2023 and March 1,
2024, the &ldquo;Merger Agreement&rdquo;). NewGenIvf&rsquo;s ordinary shares into which ASCA&rsquo;s ordinary shares and rights were
converted upon completion of the Reincorporation Merger, and NewGenIvf&rsquo;s warrants to purchase NewGenIvf&rsquo;s ordinary shares
into which ASCA&rsquo;s warrants to purchase ASCA&rsquo;s ordinary shares were converted upon completion of the Reincorporation Merger,
are deemed registered under Section 12(b) of the Securities Exchange Act of 1934, as amended, by operation of paragraph (a) of Rule 12g-3
thereunder. NewGenIvf hereby reports the succession in accordance with Rule 12g-3(f) under the Exchange Act, on Form 6-K using the EDGAR
format type 8-K12B, as notice that NewGenIvf has become a successor issuer to ASCA pursuant to Rule 12g-3(a) under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of the joint press release is furnished as Exhibit 99.1 to this Report on Form 6-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
Events</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
total of 1,862,085 shares were redeemed in connection with the consummation of the business combination. Each redeemed share will receive
approximately $11.16 per share shortly after the closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
INDEX</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No.</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea020326701ex99-1_newgenivf.htm" STYLE="-sec-extract: exhibit">Joint Press Release of the Company and ASCA, dated April 3, 2024.</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURE</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
April 3, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NewGenIvf
    Group Limited</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Wing Fung Alfred Siu</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wing Fung Alfred Siu</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea020326701ex99-1_newgenivf.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Exhibit 99.1</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;<IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">NewGenIvf and A SPAC I Announce Closing of Business
Combination</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: center"><I>NewGenIvf&rsquo;s shares and warrants
are expected to begin trading on the Nasdaq Capital Market under the tickers &ldquo;NIVF&rdquo; and &ldquo;NIVFW&rdquo;, respectively,
on April 4, 2024</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">NEW YORK, April 3, 2024 /PRNewswire/ -- NewGenIvf
Limited (&ldquo;NewGen&rdquo; or the &ldquo;Company&rdquo;), a comprehensive fertility services provider in Asia helping couples and individuals
obtain access to fertility treatments, and A SPAC I Acquisition Corp. (NASDAQ: ASCA) (&ldquo;A SPAC I&rdquo;), a publicly traded special
purpose acquisition company, today announced the completion of their previously announced business combination (the &ldquo;Business Combination&rdquo;).
The combined company will be named &quot;NewGenIvf Group Limited&quot; (&ldquo;NewGenIvf Group&rdquo;) and its shares and warrants are
expected to begin trading on the Nasdaq Capital Market under the tickers &quot;NIVF&quot;, and &quot;NIVFW&quot;, respectively, on April
4, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Mr. Siu Wing Fung Alfred, Founder, Chairman, and CEO
of NewGen commented, &ldquo;We are thrilled to announce our upcoming debut on the Nasdaq as we complete our business combination with
A SPAC I. Demand for fertility services is growing across Asia, and we are uniquely positioned to take advantage of this emerging opportunity.
We believe our public listing will help us to accelerate our growth and execute on our long-term vision, bolstering our ability to provide
accessible, comprehensive fertility solutions to individuals and couples who need them. I am proud of all we have accomplished to date,
and I am eager to begin the next phase of our company&rsquo;s journey.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Claudius Tsang, CEO, CFO and Chairman of A SPAC I,
commented, &ldquo;We are excited to complete the Business Combination, and to see what NewGen will accomplish in this new chapter of its
story. We believe that the company will continue to play a significant role in Asia&rsquo;s burgeoning fertility services market.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Advisors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Jun He Law Offices served as the legal advisor to
NewGen in connection with the Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Loeb &amp; Loeb LLP and Ogier served as legal counsel
to A SPAC I in connection with the Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>About NewGen</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">NewGen is a comprehensive fertility services provider
in Asia helping couples and individuals obtain access to fertility treatments. With a mission to aid couples and individuals in building
families regardless of fertility challenges, NewGen has dedicated itself to creating increased access to infertility treatment and providing
comprehensive fertility services for its customers. NewGen Group and its management have over a decade of experience in the fertility
industry. NewGen's clinics are located in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including
comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions,
respectively. To learn more, visit www.newgenivf.com. The information contained on, or accessible through, NewGen's website is not incorporated
by reference into this press release, and you should not consider it a part of this press release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="image_002.jpg" ALT="">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>About A SPAC I Acquisition Corp.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A SPAC I Acquisition Corp. was a blank check company
sponsored by A SPAC (Holdings) Acquisition Corp., a British Virgin Islands company, and formed for the purpose of effecting a merger,
share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">This press release contains forward-looking statements. These statements
are made under the &quot;safe harbor&quot; provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking
statements generally are identified by the words &quot;believe,&quot; &quot;project,&quot; &quot;expect,&quot; &quot;anticipate,&quot;
&quot;estimate,&quot; &quot;intend,&quot; &quot;strategy,&quot; &quot;future,&quot; &quot;opportunity,&quot; &quot;plan,&quot; &quot;may,&quot;
&quot;should,&quot; &quot;will,&quot; &quot;would,&quot; &quot;will be,&quot; &quot;will continue,&quot; &quot;will likely result,&quot;
and similar expressions. Without limiting the generality of the foregoing, the forward-looking statements in this press release include
descriptions of the Company's or NewGenIvf Group&rsquo;s future commercial operations. Forward-looking statements are predictions, projections
and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks
and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press
release, such as the Company's or NewGenIvf Group&rsquo;s inability to implement its business plans, identify and realize additional opportunities,
or meet or exceed its financial projections and changes in the regulatory or competitive environment in which the Company or NewGenIvf
Group operates. You should carefully consider the foregoing factors and the other risks and uncertainties described in NewGenIvf Group&rsquo;s
Annual Report on Form 20-F and other documents filed or to be filed by NewGenIvf Group&rsquo;s with the U.S. Securities and Exchange Commission
(the &quot;SEC&quot;) from time to time, which could cause actual events and results to differ materially from those contained in the
forward-looking statements. Copies of these documents are available on the SEC's website, www.sec.gov. All information provided herein
is as of the date of this press release, and the Company and NewGenIvf Group undertakes no obligation to update any forward-looking statement,
except as required under applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Investor Relations Contact</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">ICR, LLC<BR>
Robin Yang<BR>
Phone: +1 (212) 537-4406<BR>
Email:&nbsp;Newgenivf.IR@icrinc.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !Q KH# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%5)=3L8)6CENX4=>JLX!%-_MC3?^?Z#_OL5'M(
M+JBU3F^C^XNT52_MC3?^?Z#_ +[%']L:;_S_ $'_ 'V*/:0[K[Q^RG_*_N9=
MHJE_;&F_\_T'_?8H_MC3?^?Z#_OL4>TAW7WA[*?\K^YEVBJ7]L:;_P _T'_?
M8H_MC3?^?Z#_ +[%'M(=U]X>RG_*_N9=HJE_;&F_\_T'_?8H_MC3?^?Z#_OL
M4>TAW7WA[*?\K^YEVBJ7]L:;_P _T'_?8H_MC3?^?Z#_ +[%'M(=U]X>RG_*
M_N9=HJE_;&F_\_T'_?8H_MC3?^?Z#_OL4>TAW7WA[*?\K^YEVBJ7]L:;_P _
MT'_?8H_MC3?^?Z#_ +[%'M(=U]X>RG_*_N9=HJE_;&F_\_T'_?8H_MC3?^?Z
M#_OL4>TAW7WA[*?\K^YEVBJ7]L:;_P _T'_?8H_MC3?^?Z#_ +[%'M(=U]X>
MRG_*_N9=HJE_;&F_\_T'_?8H_MC3?^?Z#_OL4>TAW7WA[*?\K^YEVBJ7]L:;
M_P _T'_?8H_MC3?^?Z#_ +[%'M(=U]X>RG_*_N9=HJE_;&F_\_T'_?8H_MC3
M?^?Z#_OL4>TAW7WA[*?\K^YEVBJ7]L:;_P _T'_?8H_MC3?^?Z#_ +[%'M(=
MU]X>RG_*_N9=HJE_;&F_\_T'_?8H_MC3?^?Z#_OL4>TAW7WA[*?\K^YEVBJ7
M]L:;_P _T'_?8H_MC3?^?Z#_ +[%'M(=U]X>RG_*_N9=HJE_;&F_\_T'_?8H
M_MC3?^?Z#_OL4>TAW7WA[*?\K^YEVBJ7]L:;_P _T'_?8H_MC3?^?Z#_ +[%
M'M(=U]X>RG_*_N9=HJE_;&F_\_T'_?8H_MC3?^?Z#_OL4>TAW7WA[*?\K^YE
MVBJ7]L:;_P _T'_?8H_MC3?^?Z#_ +[%'M(=U]X>RG_*_N9=HJE_;&F_\_T'
M_?8H_MC3?^?Z#_OL4>TAW7WA[*?\K^YEVBJ7]L:;_P _T'_?8H_MC3?^?Z#_
M +[%'M(=U]X>RG_*_N9=HJE_;&F_\_T'_?8H_MC3?^?Z#_OL4>TAW7WA[*?\
MK^YEVBJ7]L:;_P _T'_?8H_MC3?^?Z#_ +[%'M(=U]X>RG_*_N9=HJE_;&F_
M\_T'_?8H_MC3?^?Z#_OL4>TAW7WA[*?\K^YEVBJ7]L:;_P _T'_?8H_MC3?^
M?Z#_ +[%'M(=U]X>RG_*_N9=HJE_;&F_\_T'_?8H_MC3?^?Z#_OL4>TAW7WA
M[*?\K^YEVBJ7]L:;_P _T'_?8H_MC3?^?Z#_ +[%'M(=U]X>RG_*_N9=HJE_
M;&F_\_T'_?8H_MC3?^?Z#_OL4>TAW7WA[*?\K^YEVBJ7]L:;_P _T'_?8H_M
MC3?^?Z#_ +[%'M(=U]X>RG_*_N9=HJE_;&F_\_T'_?8H_MC3?^?Z#_OL4>TA
MW7WA[*?\K^YEVBJ7]L:;_P _T'_?8H_MC3?^?Z#_ +[%'M(=U]X>RG_*_N9=
MHJE_;&F_\_T'_?8H_MC3?^?Z#_OL4>TAW7WA[*?\K^YEVBJ7]L:;_P _T'_?
M8H_MC3?^?Z#_ +[%'M(=U]X>RG_*_N9=HJE_;&F_\_T'_?8H_MC3?^?Z#_OL
M4>TAW7WA[*?\K^YEVBJ7]L:;_P _T'_?8H_MC3?^?Z#_ +[%'M(=U]X>RG_*
M_N9=HJE_;&F_\_T'_?8H_MC3?^?Z#_OL4>TAW7WA[*?\K^YEVBJ7]L:;_P _
MT'_?8H_MC3?^?Z#_ +[%'M(=U]X>RG_*_N9=HJE_;&F_\_T'_?8H_MC3?^?Z
M#_OL4>TAW7WA[*?\K^YEVBJ]O?VETY2WN(Y6 R0C9XJQ5)IZHAIIV84444Q!
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
G 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !Q KH# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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G 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
